219 related articles for article (PubMed ID: 23251421)
1. Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
Sadarangani M; Hoe JC; Callaghan MJ; Jones C; Chan H; Makepeace K; Daniels-Treffandier H; Deadman ME; Bayliss C; Feavers I; van der Ley P; Pollard AJ
PLoS One; 2012; 7(12):e51045. PubMed ID: 23251421
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
Jones C; Sadarangani M; Lewis S; Payne I; Saleem M; Derrick JP; Pollard AJ
PLoS One; 2016; 11(4):e0154153. PubMed ID: 27111850
[TBL] [Abstract][Full Text] [Related]
3. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
[TBL] [Abstract][Full Text] [Related]
4. Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
Callaghan MJ; Lewis S; Sadarangani M; Bailey SE; Chan H; Ferguson DJ; Derrick JP; Feavers I; Maiden MC; Pollard AJ
Infect Immun; 2011 Jul; 79(7):2810-8. PubMed ID: 21464082
[TBL] [Abstract][Full Text] [Related]
5. Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.
Zariri A; van Dijken H; Hamstra HJ; van der Flier M; Vidarsson G; van Putten JP; Boog CJ; van den Dobbelsteen G; van der Ley P
Vaccine; 2013 Nov; 31(47):5585-93. PubMed ID: 23933369
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins.
de Jonge MI; Hamstra HJ; Jiskoot W; Roholl P; Williams NA; Dankert J; van Alphen L; van der Ley P
Vaccine; 2004 Sep; 22(29-30):4021-8. PubMed ID: 15364452
[TBL] [Abstract][Full Text] [Related]
7. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
Matthias KA; Reveille A; Connolly KL; Jerse AE; Gao YS; Bash MC
Vaccine; 2020 Feb; 38(10):2396-2405. PubMed ID: 32037226
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of truncated NhhA protein as a candidate meningococcal vaccine antigen.
Peak IR; Srikhanta YN; Weynants VE; Feron C; Poolman JT; Jennings MP
PLoS One; 2013; 8(9):e72003. PubMed ID: 24039731
[TBL] [Abstract][Full Text] [Related]
9. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
[TBL] [Abstract][Full Text] [Related]
10. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
11. Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria.
Sadarangani M; Pollard AJ; Gray-Owen SD
FEMS Microbiol Rev; 2011 May; 35(3):498-514. PubMed ID: 21204865
[TBL] [Abstract][Full Text] [Related]
12. The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.
Pinto VB; Burden R; Wagner A; Moran EE; Lee CH
PLoS One; 2013; 8(11):e79304. PubMed ID: 24244473
[TBL] [Abstract][Full Text] [Related]
13. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
Tunheim G; Naess LM; Acevedo R; Fjeldheim ÅK; Bolstad K; García L; Cardoso D; Aase A; Zayas C; González H; Rosenqvist E; Norheim G
Vaccine; 2014 Nov; 32(49):6631-8. PubMed ID: 25305564
[TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.
Acevedo R; Zayas C; Norheim G; Fernández S; Cedré B; Aranguren Y; Cuello M; Rodriguez Y; González H; Mandiarote A; Pérez M; Hernández M; Hernández-Cedeño M; González D; Brorson SH; Rosenqvist E; Naess L; Tunheim G; Cardoso D; García L
Pharmacol Res; 2017 Jul; 121():194-201. PubMed ID: 28495657
[TBL] [Abstract][Full Text] [Related]
15. Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.
Pajon R; Fergus AM; Koeberling O; Caugant DA; Granoff DM
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1302. PubMed ID: 21909444
[TBL] [Abstract][Full Text] [Related]
16. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.
Zhu D; Zhang Y; Barniak V; Bernfield L; Howell A; Zlotnick G
Infect Immun; 2005 Oct; 73(10):6838-45. PubMed ID: 16177362
[TBL] [Abstract][Full Text] [Related]
19. The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.
Hung MC; Salim O; Williams JN; Heckels JE; Christodoulides M
Infect Immun; 2011 Sep; 79(9):3784-91. PubMed ID: 21708989
[TBL] [Abstract][Full Text] [Related]
20. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
Semchenko EA; Tan A; Borrow R; Seib KL
Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
